Top compounds associated with response to LDB3


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.09
mRNA thapsigargin gCSI pan-cancer AAC -0.091 0.09
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.058 0.09
mRNA DMOG GDSC1000 pan-cancer AAC -0.054 0.09
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA Pyrimethamine GDSC1000 pan-cancer AAC 0.085 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA prima-1 CTRPv2 pan-cancer AAC 0.05 0.1
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.069 0.1
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.046 0.1
Download CSV